Spark Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-35,700
Closed -$1.13M 798
2016
Q3
$1.13M Sell
35,700
-113,100
-76% -$3.29M 0.09% 315
2016
Q2
$4.18M Buy
148,800
+54,800
+58% +$2.15M 0.39% 54
2016
Q1
$3.42M Hold
94,000
0.35% 76
2015
Q4
$3.76M Sell
94,000
-6,500
-6% -$227K 0.48% 43
2015
Q3
$2.86M Hold
100,500
0.37% 66
2015
Q2
$3.31M Buy
100,500
+50,000
+99% +$1.55M 0.46% 45
2015
Q1
$1.45M Buy
50,500
+18,900
+60% +$542K 0.2% 163
2014
Q4
$860K Hold
31,600
0.14% 208
2014
Q3
$673K Sell
31,600
-41,000
-56% -$939K 0.1% 281
2014
Q2
$1.63M Sell
72,600
-55,900
-44% -$1.3M 0.24% 138
2014
Q1
$3.25M Buy
128,500
+61,500
+92% +$1.55M 0.51% 34
2013
Q4
$1.54M Buy
67,000
+15,800
+31% +$329K 0.27% 125
2013
Q3
$975K Sell
51,200
-9,400
-16% -$168K 0.22% 142
2013
Q2
$873K Buy
+60,600
New +$877K 0.23% 124

Other funds holding EBS

Spark Investment Management's EBS Position: Q4 2016 in Review

Spark Investment Management sold out of Emergent Biosolutions (EBS) in Q4 2016, closing a stake of 35,700 shares — an estimated $1.13M sold.

Spark Investment Management first reported a position in EBS in Q2 2013 and held it in 14 quarters. The position peaked at $4.18M in Q2 2016. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • Spark Investment Management reported no remaining Emergent Biosolutions position as of Q4 2016 after selling out during the quarter.
  • Spark Investment Management sold 35,700 Emergent Biosolutions shares in Q4 2016, an estimated $1.13M.
  • Spark Investment Management first reported a position in Emergent Biosolutions in Q2 2013 and held it in 14 quarters.
  • Spark Investment Management's Emergent Biosolutions position peaked at $4.18M in Q2 2016.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on Spark Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.